KRTAP5-2
gene geneOn this page
Also known as KRTAP5.2KRTAP5-8
Summary
KRTAP5-2 (keratin associated protein 5-2, HGNC:23597) is a protein-coding gene on chromosome 11p15.5, encoding Keratin-associated protein 5-2 (Q701N4). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to be located in cytosol.
Source: NCBI Gene 440021 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_001004325
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23597 |
| Approved symbol | KRTAP5-2 |
| Name | keratin associated protein 5-2 |
| Location | 11p15.5 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.2, KRTAP5-8 |
| Ensembl gene | ENSG00000205867 |
| Ensembl biotype | protein_coding |
| Entrez | 440021 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000412090
RefSeq mRNA: 1 — MANE Select: NM_001004325
NM_001004325
CCDS: CCDS31331
Canonical transcript exons
ENST00000412090 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001667178 | 1597177 | 1598294 |
Expression profiles
Bgee: expression breadth broad, 77 present calls, max score 67.28.
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| prefrontal cortex | UBERON:0000451 | 67.28 | gold quality |
| frontal cortex | UBERON:0001870 | 57.18 | gold quality |
| primary visual cortex | UBERON:0002436 | 54.49 | gold quality |
| cerebellum | UBERON:0002037 | 54.33 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 53.80 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.52 | gold quality |
| duodenum | UBERON:0002114 | 48.67 | gold quality |
| granulocyte | CL:0000094 | 48.30 | silver quality |
| tonsil | UBERON:0002372 | 47.46 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 46.90 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 46.71 | gold quality |
| sural nerve | UBERON:0015488 | 46.47 | silver quality |
| cerebral cortex | UBERON:0000956 | 45.77 | gold quality |
| right frontal lobe | UBERON:0002810 | 43.44 | gold quality |
| brain | UBERON:0000955 | 42.74 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 42.18 | gold quality |
| apex of heart | UBERON:0002098 | 41.75 | silver quality |
| gall bladder | UBERON:0002110 | 40.66 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 40.32 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 40.16 | silver quality |
| hypothalamus | UBERON:0001898 | 39.97 | gold quality |
| muscle tissue | UBERON:0002385 | 39.35 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 39.15 | gold quality |
| nucleus accumbens | UBERON:0001882 | 37.96 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| caudate nucleus | UBERON:0001873 | 37.12 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| putamen | UBERON:0001874 | 36.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting KRTAP5-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-4648 | 99.91 | 67.00 | 710 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-5011-3P | 98.63 | 64.81 | 638 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-1199-5P | 98.44 | 66.51 | 829 |
| HSA-MIR-6751-3P | 98.44 | 66.35 | 835 |
| HSA-MIR-4768-3P | 98.16 | 66.02 | 2330 |
| HSA-MIR-211-3P | 98.14 | 66.77 | 1052 |
| HSA-MIR-4518 | 98.12 | 66.82 | 1030 |
| HSA-MIR-1266-5P | 97.71 | 66.92 | 1052 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-1245A | 96.33 | 66.25 | 498 |
| HSA-MIR-8079 | 96.33 | 66.11 | 484 |
| HSA-MIR-139-3P | 95.24 | 63.10 | 316 |
| HSA-MIR-6750-5P | 93.94 | 66.68 | 797 |
Literature-anchored findings (GeneRIF, showing 1)
- CK7 and Cam 5.2 expression may occur in SCC. A panel including Ber-Ep4 is advisable for immunohistochemical differentiation of EPD from SCC. (PMID:23590728)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap5-4 | ENSMUSG00000045236 |
| mus_musculus | Krtap5-1 | ENSMUSG00000066100 |
| mus_musculus | Krtap5-5 | ENSMUSG00000073785 |
| mus_musculus | Krtap5-22 | ENSMUSG00000109655 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 5-2 — Q701N4 (reviewed: Q701N4)
Alternative names: Keratin-associated protein 5-8, Keratin-associated protein 5.2, Keratin-associated protein 5.8, Ultrahigh sulfur keratin-associated protein 5.2
All UniProt accessions (1): Q701N4
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Restricted to hair root, not detected in any other tissues.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001004325* (*=MANE)
Domains & families (InterPro)
UniProt features (8 total): repeat 6, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q701N4-F1 | 39.47 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 47 (showing top):
DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, chr11q13, MARTINEZ_RB1_TARGETS_DN, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, LEE_AGING_MUSCLE_UP, DURCHDEWALD_SKIN_CARCINOGENESIS_UP, MULLIGHAN_MLL_SIGNATURE_2_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, MULLIGHAN_MLL_SIGNATURE_1_DN, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MIKKELSEN_MEF_LCP_WITH_H3K27ME3, FIGUEROA_AML_METHYLATION_CLUSTER_1_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
114 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP5-2 | OR6X1 | Q8NH79 | 166 |
| KRTAP5-2 | OR6F1 | Q8NGZ6 | 166 |
| KRTAP5-2 | ACTR5 | Q9H9F9 | 102 |
| KRTAP5-2 | INO80C | Q6PI98 | 99 |
| KRTAP5-2 | K7ENP7 | K7ENP7 | 99 |
| KRTAP5-2 | RUVBL1 | P82276 | 90 |
| KRTAP5-2 | RUVBL2 | Q9Y230 | 90 |
| KRTAP5-2 | OR1J4 | Q8NGS1 | 77 |
| KRTAP5-2 | ACTL6B | O94805 | 67 |
| KRTAP5-2 | ACTR8 | Q9H981 | 66 |
| KRTAP5-2 | KRTAP11-1 | Q8IUC1 | 62 |
| KRTAP5-2 | KRT74 | Q7RTS7 | 53 |
| KRTAP5-2 | KRT71 | Q3SY84 | 44 |
| KRTAP5-2 | FUCA2 | Q9BTY2 | 0 |
| KRTAP5-2 | NUFIP2 | Q7Z417 | 0 |
| KRTAP5-2 | EMC7 | Q9NPA0 | 0 |
| KRTAP5-2 | CHD5 | Q8TDI0 | 0 |
IntAct
152 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP5-2 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP5-2 | LELP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | UBE2I | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3C | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1E | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2D | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2C | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | LCE1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | KRTAP4-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3B | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | MACO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | LMNTD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OPCML | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1F | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRY2 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | CRCT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TACSTD2 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3E | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | DHRS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-2 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MT1B | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DLGAP3 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (61): KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 45 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 24 | 39.3× | 2e-33 |
| Formation of the cornified envelope | 15 | 38.8× | 2e-19 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 14 | 99.3× | 1e-23 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
777 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:71538228:G:T | donor_gain | 0.9700 |
| 11:71538501:G:GG | donor_gain | 0.9700 |
| 11:1598083:A:C | donor_gain | 0.9600 |
| 11:71538498:GCT:G | donor_gain | 0.9600 |
| 11:1598099:C:A | donor_gain | 0.9500 |
| 11:1598020:G:C | donor_gain | 0.9400 |
| 11:1598181:A:AT | donor_gain | 0.9400 |
| 11:71538202:C:G | donor_gain | 0.9400 |
| 11:71538227:G:GT | donor_gain | 0.9400 |
| 11:71538524:GGCT:G | donor_gain | 0.9400 |
| 11:71538525:GCTG:G | donor_gain | 0.9400 |
| 11:71538668:G:GT | donor_gain | 0.9400 |
| 11:71538669:A:T | donor_gain | 0.9400 |
| 11:1598038:TGG:T | donor_gain | 0.9200 |
| 11:1597509:C:CT | acceptor_gain | 0.9100 |
| 11:1597509:C:T | acceptor_gain | 0.9100 |
| 11:1598098:T:TA | donor_gain | 0.9100 |
| 11:71538123:G:T | donor_gain | 0.9100 |
| 11:1597421:C:T | acceptor_gain | 0.9000 |
| 11:1597994:C:A | donor_gain | 0.9000 |
| 11:1597421:C:CT | acceptor_gain | 0.8900 |
| 11:1598055:CGGG:C | donor_gain | 0.8900 |
| 11:1598224:G:GA | donor_gain | 0.8900 |
| 11:71538750:GGC:G | donor_gain | 0.8900 |
| 11:1597514:C:CT | acceptor_gain | 0.8800 |
| 11:71538123:G:GT | donor_gain | 0.8700 |
| 11:71538437:GGCT:G | donor_gain | 0.8700 |
| 11:71538438:GCTG:G | donor_gain | 0.8700 |
| 11:71538727:GAC:G | donor_gain | 0.8600 |
| 11:1598180:C:CT | donor_gain | 0.8500 |
AlphaMissense
1142 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:1597721:A:C | I177S | 0.671 |
| 11:1597843:G:C | S136R | 0.627 |
| 11:1597843:G:T | S136R | 0.627 |
| 11:1597845:T:G | S136R | 0.627 |
| 11:1597813:G:C | S146R | 0.620 |
| 11:1597813:G:T | S146R | 0.620 |
| 11:1597815:T:G | S146R | 0.620 |
| 11:1597783:G:C | S156R | 0.617 |
| 11:1597783:G:T | S156R | 0.617 |
| 11:1597785:T:G | S156R | 0.617 |
| 11:1597891:C:A | K120N | 0.603 |
| 11:1597891:C:G | K120N | 0.603 |
| 11:1597723:C:A | K176N | 0.592 |
| 11:1597723:C:G | K176N | 0.592 |
| 11:1597721:A:G | I177T | 0.581 |
dbSNP variants (sampled 300 via entrez): RS1000050507 (11:1599360 A>G), RS1004681179 (11:1597189 C>A,T), RS1005243444 (11:1596975 T>TC), RS1006639209 (11:1600087 C>A,T), RS1006811142 (11:1599154 C>A,T), RS1007169784 (11:1599532 A>G), RS1008194326 (11:1596864 C>A,T), RS1012230484 (11:1599000 A>G), RS1015275259 (11:1597197 G>A), RS1015866895 (11:1598642 T>C), RS1016818572 (11:1599806 C>T), RS1017276425 (11:1600097 G>C,T), RS1019747468 (11:1597846 G>A), RS1019915227 (11:1599190 G>T), RS1021349136 (11:1597286 A>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Leflunomide | increases expression | 1 |
| Cadmium | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.